Clinical Trial Update: A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating how NNC0487-0111 affects food intake, appetite, and post-meal metabolism in people with obesity; recruitment status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: NOT_YET_RECRUITING